Apellis Pharmaceuticals
Price & Volume
Stats
See moreOpen | $24.08 |
Previous Close | $23.90 |
Day Range | $24.08-$24.85 |
52W Range | $16.10-$41.94 |
Market Cap | $3B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $754.6M |
Revenue Growth (YoY) | -10.6% |
Gross Profit (12 Mos) | $313.8M |
Diluted EPS | -$1.83 |
News
See moreYahoo Finance • 13 days ago
APELLIS PHARMACEUTICALS INC (NASDAQ:APLS) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss
Yahoo Finance • 13 days ago
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
Yahoo Finance • 15 days ago
Apellis wins FDA label expansion for Empaveli in rare kidney disorders
Yahoo Finance • 16 days ago
Apellis Pharma Secures FDA Approval For EMPAVELI To Treat Rare Kidney Disorders
About
CEO | Dr. Cedric Francois M.D., Ph.D. |
CFO | Mr. Timothy E. Sullivan |
Address | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 705 |
